You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2025

AbstractFullPdf
Nov 2021320323133
Dec 202114915043
Jan 2022747733
Feb 2022848626
Mar 2022757932
Apr 202210811030
May 2022959727
Jun 2022959816
Jul 2022656824
Aug 2022737624
Sep 2022858652
Oct 2022565630
Nov 2022272915
Dec 2022373913
Jan 2023343623
Feb 2023606012
Mar 2023777825
Apr 202316163
May 2023282817
Jun 2023232516
Jul 2023282821
Aug 2023303012
Sep 2023232316
Oct 2023414116
Nov 2023404015
Dec 2023444421
Jan 2024181914
Feb 2024343419
Mar 2024505117
Apr 2024525219
May 2024555514
Jun 2024505013
Jul 2024434525
Aug 2024303215
Sep 2024303014
Oct 2024444428
Nov 2024495034
Dec 2024424339
Jan 2025898938
Feb 202514014063
Mar 2025585824
Apr 2025737353
May 2025494937
Jun 2025394049
Jul 2025110
Sep 2025110
Total273427791210